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abstract
Objective: Specific knowledge on neurocognitive functioning in (syndrome based) intellectual disability (ID) is 
important for the assessment, treatment and support of patients in whom this condition is present. The present study 
investigates the applicability of computerized neurocognitive testing in patients with rare monogenetic ID disorders by 
(1) determining the developmental age at which the use is contributive and (2) investigating the specificity of the tests for 
neurocognitive functions, independent of the id.
Method: A total of 56 patients with monogenetic ID disorders, including Kleefstra Syndrome (KS; n=24), and a contrast 
group of various rare disorders (n= 32) participated. Assessments included (a) the Vineland Adaptive Behavior Scale 
(VABS) interview to calculate developmental age and (b) four simplified subtests of the Cambridge Neuropsychological 
Test Automated Battery (CANTAB). A cut-off in developmental age was estimated based on the ability to complete the 
CANTAB-tasks. A developmental age of 2,5 years and older allows practical application in our cohort. 
Results: There was no significant correlation between developmental age and results on cognitive tests (range: -0,171 
≤ ρ ≤ 0,336 with p-values > 0,07). A between-group comparison shows a larger dropout in the KS sub cohort (based on 
cross tabulation) and longer latencies on the motor screening test.
Conclusions: Our results indicate that simplified CANTAB tasks are suitable for application in the ID population to 
unravel individual neurocognitive characteristics and, hence also, syndrome specific neurocognitive features. Furthermore, 
successful employment of computerized testing in this complex population may be the only way to avoid the restraints 
of standard classificatory clinical procedures that aim at categories of patients rather than at the individual patient with its 
unique cognitive neuropsychiatric complexion. 
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introduction
Intellectual Disabilities (ID) comprise a 
heterogeneous disease category, characterized by 
deficits in adaptive as well as intellectual functioning 
that manifest at a young age, typically during the 
developmental period (APA 2013). Traditionally it is 
categorized by levels of adaptive functioning; in other 
words, the severity reflects the level of support that is 
required to function in daily life.
with recent advances in genetic techniques, people 
with intellectual disabilities (ID) are more often 
diagnosed with a genetic syndrome underlying their 
ID (Willemsen and Kleefstra 2013, Gilissen et al. 
2014, Vissers et al. 2016, DDD-study 2017). From a 
clinical perspective, in particular when challenging 
behaviors are present, it is not only important to 
have an estimate of a patient’s level of intellectual 
functioning, but also to obtain full understanding of the 
neurocognitive functioning by including measures of 
attention, memory, executive functioning, and affective 
information processing. since these various cognitive-
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tests, which were originally developed for the general 
population, can be applied in the id population.
In this study, we aim to determine the applicability 
of computerized neurocognitive testing for diagnostic 
assessment and phenotyping of genetic syndromes. 
Specifically, we are interested in what level of 
functioning is required to perform such neurocognitive 
tests and to what extent neurocognitive data are 
syndrome specific. Therefore, the use of four simplified 
tablet based neuropsychological tests from the widely 
used Cambridge Neuropsychological Test Automated 
Battery (CANTAB; (2017)) is investigated in patients 
with rare monogenetic disorders, with a main focus on 
Kleefstra Syndrome (KS, main clinical characteristics 
are listed in table 1) (Kleefstra et al. 2006, Willemsen 
et al. 2012). The specific group of KS patients has been 
chosen because we can build upon our expertise with 
this syndrome, already inventoried knowledge about the 
clinical picture, both adaptive as well as maladaptive 
(summary in table 1). Furthermore, for a rare 
neurodevelopmental disorder, this cohort is relatively 
large (n= 24) and comprises, at the time of inclusion, 
all known patients in the Netherlands and Belgium 
(Vermeulen et al. 2017).
In sum, the purpose of this study is fourfold, 
namely (1) to define at a group level (the “overall”-
level) a cut-off value in developmental age for the 
meaningful application of these tests. In other words, 
we examine whether it is possible to disentangle the 
level of functioning from other cognitive characteristics 
(for example memory, cognitive flexibility and 
processing time) in a population with low general 
levels of functioning. Then, we want to establish at the 
inter-individual level (2) whether these tests provide 
additional information on neurocognitive functioning, 
incremental to the information already available from 
the lower general level of functioning. Consequently, 
(3) at this inter-individual level, we expect higher levels 
of dropout on these neuropsychological tests at lower 
levels of developmental age. And finally, we want to 
explore at the intra-individual level (4) if these tests 
provide additional information about the individual 
affective processes are essential for adequate daily 
functioning and can have a major impact on the quality 
of life, strengths and weaknesses thus identified are 
of utmost importance for the design and selection of 
targeted treatment - e.g., (Egger et al. 2007, Verhoeven 
and Egger 2014). As a matter of fact, with the advance 
of genetic testing and the rise of novel defined 
syndromes, it is increasingly noticed that such profiles of 
neurocognitive functioning are associated with specific 
genetic disorders (Roelofs et al. 2015, Egger et al. 2016). 
Results on neuropsychological tests in more established 
genetic syndromes, such as Down syndrome, 22q11.2 
deletion syndrome, Williams syndrome, Prader-Willi 
syndrome, and Noonan syndrome, showed potential to 
optimize daily guidance as well as to obtain objective 
measures for follow-up studies and therapeutic 
interventions (Edgin et al. 2010, Rhodes et al. 2010, 
van Nieuwpoort et al. 2011, Wingbermühle et al. 2012, 
Liogier d’Ardhuy et al. 2015, Roelofs et al. 2016).
While neurocognitive functioning has shown to 
be a well-established factor in the understanding of 
neurodevelopmental (genetic) disorders, there are 
specific complications that may arise when performing 
neurocognitive assessment in patients with ID. For 
instance, several tests rely on (verbal) instructions that 
require abilities in conceptual reasoning on average-and-
above levels of intelligence. in addition, regarding the 
development of normative scores, patients with ID are 
not included and, consequently, differential performance 
in the low-IQ range may not reliably and validly detected. 
furthermore, to address above issues, data are often 
obtained through indirect measurement, for example with 
proxy ratings via interviews or questionnaires. Although 
these are invaluable sources of information, they may 
be less reliable due to specific biases in particular when 
applied within the ID population (Havdahl et al. 2016, 
Vermeulen et al. 2017). All this often leaves the clinician 
relatively empty-handed, that is, with few possibilities 
to disentangle syndrome specific features from features 
caused by the level of ID and to build their interventions 
on the individual neurocognitive profile. Therefore, 
it is important to consider if and how neurocognitive 
Table 1. Background information on Kleefstra Syndrome
Genetic defect
Kleefstra et al. (2006) Chromosomal microdeletion or intragenic EHMT1 mutation, 
both resulting in a similar clinical phenotype
Clinical characteristics, somatic and psychiatric comorbidity
Kleefstra et al. (2006), Willemsen et 
al. (2012), Verhoeven et al. (2011), 
Vermeulen et al. (2017a), Vermeulen 
et al. (2017b)
General: Trias ID, childhood hypotonia and prominent facial 
features
Somatic: Congenital heart abnormality, epilepsy, constipation
Psychiatric: Autism spectrum disorder, psychosis, apathy, 
major depressive disorder
Translational research in animal models
Kramer et al. (2011) Mutant EHMT1 Drosophila melanogaster: disturbed motor 
behavior, non-associative learning and courtship complex 
memory 
Balemans et al. (2010) EHMT1 knock-out mice: Problems with stimulus processing, 
high levels of anxiety, low levels of baseline activity, 
perseveration and deviation in social reactions to strangers
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patient for personalized diagnosis and treatment and 
how this results in a personalized practice. Thus, across 
the overall, inter-individual, and intra-individual levels, 
four questions are examined to systematically map 
the additional value of these simplified computerized 
neuropsychological tests for application in the ID 
population with monogenetic disorders.
method
for a detailed description of the recruitment of 
patients and the psychometric properties of the Vineland 
Adaptive Behavior Scale (VABS), we refer to our 
previous study (Vermeulen et al. 2017). 
Participants
A total of 56 patients were included: 24 with Kleefstra 
Syndrome (EHMT1 intragenic deletion or mutation) 
and 32 contrast participants with various monogenetic 
disorders. patient characteristics and the monogenetic 
disorders are displayed in table 2.
Informed consent was obtained by legal 
representatives and included in the patient file. The 
medical research ethics committee Cmo/metC 
arnhem-nijmegen, the netherlands, approved the 
study (NL43187.091.13), which was performed in full 
accordance with the Declaration of Helsinki. 
Instruments
Vineland Adaptive Behavior Scale. the dutch 
adaptation of the vineland adaptive behavior scale 
(Sparrow 1984) is a widely used clinical interview, for 
determining the level of adaptive functioning (expressed 
in a developmental age) of people with an intellectual 
disability of three domains: communication skills, daily 
living skills, and social skills. based on these, a total 
score is available. 
Cambridge Neuropsychological Test Automated 
Battery. The Cambridge Neuropsychological Test 
Automated Battery (CANTAB, 2017) consists 
of a computer administrated set of (nonverbal) 
neuropsychological tests developed to examine specific 
components of cognition. the Cantab has been 
widely used in academic research and in clinical trials, 
and tests hold acceptable levels of concurrent validity 
and test-retest reliability (Lowe and Rabbitt 1998). 
Subtests are graded in difficulty, minimizing floor and 
ceiling effects, and allow for use in a wide variety of 
ages and conditions. participants are given multiple 
training trials to learn the requirements of each task, 
and detailed recording of responses is made possible by 
using a touch-sensitive screen.
From earlier research with CANTAB tasks in Down 
syndrome (Edgin et al. 2010, Edward and Del Campo 
2017) developed simplified versions of four CANTAB 
subtests that were applied in the present study. They are 
described below and were performed in the presented 
sequence:
1. The Motor Screening Test (MOT) is a training 
procedure designed to introduce the subject to the 
touch screen. in our cohort it also is an estimate to 
reactivity, which could not be tested with an official 
reaction time test, because of the complexity of the 
latter (pushing a button instead of the touchscreen 
during the task). The simplified version is comparable 
to the normal clinical mode, but uses a high visibility 
mode.
2. The Pattern Recognition Memory (PRM) is a test 
of visual pattern recognition memory in a 2-choice 
forced discrimination paradigm. these patterns 
are designed in a way that they can’t easily be 
given verbal labels. The simplified version has 
the same amount of patterns (12). Stage 1 is 
exactly comparable to the normal clinical mode. 
Stage 2 in the simplified version includes direct 
testing of the displayed patterns, followed by 
delayed testing of these patterns. In the normal 
clinical mode, stage 2 only includes displaying the 
patterns without direct testing, so without repeat. 
The delayed recognition phase in our cohort is 
administered 10 to 20 minutes after the initial 
one, depending on the duration of the ied test 
performance.
3. The Intra-ExtraDimensional Test Shift (IED) 
is a test of rule acquisition and reversal. visual 
Table 2. Patient characteristics
group genetic defect Male: female ratio (%) biological age: mean 
(SD; min-max) in years
Total 26: 30 15,00 (± 10,248; 3-40)
Kleefstra 
Syndrome, n= 24
EHMT1 gene
16x Microdeletions
8x Mutations
9:15 (37,5% vs 62,5%) 15,42 (±10,421; 3-37)
Contrast group, 
n= 32
KANSL gene microdeletions (12x)
KANSL gene mutation (1x)
6x GATAD2B gene microdeltion
3x ANKRD11 gene mutation
3x SIN3A gene mutations
2x PACS1 gene mutations
1x FOXP2 gene mutation
1x FBOX17 gene microdeletion (2p16.3)
1x AUTS2 gene microdeletion (7q11.22)
1x YWHAE microduplication (17p13.3)
17:15 (53,1% vs 46,9%) 14,69 (± 10,272; 3-40)
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interview with the parents/ representatives to assess the 
followed by the simplified version of the CANTAB. All 
tests were performed in the vicinity of a proxy (parent, 
caregiver), who was completing questionnaires in the 
same or an adjacent (open) room. Further details on 
test procedures are described in detail in our previous 
report (Vermeulen et al. 2017). Questionnaires and an 
additional interview with the parents as well as the play 
observation with the patient were part of a larger study 
on genes and behavior (study NL43187.091.13). 
Analyses
Statistical analyses were performed using IBM 
spss statistics 22
Three different levels of measurement were 
examined when processing the results, (1) Overall level. 
The overall performance of all participants was assessed 
by using cross tabulations to answer the question at 
what developmental age testing is useful. Thereafter, 
the role of developmental age for the total group on 
results was assessed by using bivariate correlations for 
each of the Cantab subtests and the developmental 
age. (2) Inter-individual level: results between groups 
were compared. Distribution of the variables under 
research did not meet the normality-criterion, hence 
Mann-Whitney U test was used to compare results 
of KS and contrast subjects. Finally, (3) at the intra-
individual level, a profile of neurocognitive functioning 
was composed for each of the participants who were 
able to complete all tests. These profiles were inspected 
on strengths and weaknesses for the provision of clues 
for daily guidance and optimal functioning. 
discrimination, cognitive flexibility and sustained 
attention are tested. The structure is the simplified 
task is similar to the clinical mode, with exception of 
the termination criterium. In the simplified version 
the test terminates after 30 failing trials whereas the 
clinical mode terminates after 50 failing trials.
4. Paired Associate Learning (PAL) assesses visual 
memory and new learning. The simplified version 
is largely/ mainly comparable to the clinical mode. 
It also consists of 8 stages. The first 5 stages are 
similar between the simplified version and the 
clinical mode. In stage 6 the simplified version 
shows 4 patterns instead of 3 in the clinical mode. 
Stage 7 and 8 are comparable.  (8 stages. Stage 11 
pattern out of 6 boxes. Stage 2  1 pattern out of 6 
boxes. Stage 3  2 patterns out of 6 boxes. Stage 
4 2 patterns out of 6 boxes. Stage 5 3 patterns 
out of 6 boxes. Stage 6 3 patterns out of 6 boxes. 
Stage 7 6 patterns out of 6 boxes. Stage 8 8 
patterns out of 8 boxes). Each stage is composed of 
several trials, consisting of the first presentation of 
the shape(s) and followed by representation when 
the subject makes an error. The simplified version 
terminates when 6 attempts are not successful, 
whereas the clinical mode terminates after 10 repeat 
presentations.
Procedures
Patients were tested in a familiar place to reduce 
risk on sub-optimal results, e.g. distortion by fear of 
the unknown. The investigation started with a VABS 
Figure 1. Performance on CANTAB tasks
Developmental age categories (in years)
Performance on the CANTAB. For the range of developmental age (displayed in categories on the X-axis) the number 
of participants who completed (blue) vs not completed (red) the tests are displayed on the Y-axis. The results for 4 
simplified subtests of the CANTAB are displayed in each categorie on the X-axis: MOT= motor screening test. 
PRM= pattern recognition memory. IED= intra-extra dimensional test shift. PAL= paired associated learning.
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Inter-individual factors
Performance, expressed in completion rate, 
between KS and the contrast group was compared. 
Differences between the groups were calculated 
by cross tabulations for the several subtests of the 
CANTAB. The results are displayed in table 4 
and show a large drop-out in the KS group for all 
subtests. Interestingly, the KS patients with a younger 
biological age are more often able to complete the tests. 
after this, the results of the completed tests of Ks subjects 
and subjects in the contrast group were compared. For the 
CANTAB subtests, only MOT was completed by enough 
subjects to compare results. non-parametric testing on 
MOT latency (only in subjects who completed the test), 
using a Mann Whitney U test, shows a significant result 
between the groups on median latency (p < .05). Patients 
with KS had longer latencies compared to the contrast 
group. The mean latency was not significant (p=0,74) 
most probably due to the large variance in the contrast 
group (figure 3).  
results
Results are presented following the above-mentioned 
subdivision.
Overall 
The number of completed CANTAB-tests is displayed 
in figure 1. Some subjects were not able to complete 
any of the tests. As can be deduced from figure 1, in 
our cohort, MOT can be properly accomplished from a 
developmental age of 2 years (cut-off ≥ 22 months) while 
prm can be completed from a developmental age of 2.5 
years (cut-off ≥ 31 months). The results for IED and PAL 
are less clear: at a developmental age of 2.5 years and 
older, however, most subjects were able to complete the 
tests, with completing percentages of 79,2% for IED and 
70,8% for PAL.
None of the subtests showed a significant correlation 
between developmental age and test performance. 
P-values for correlation of the several subtests between 
developmental age and test results are displayed in table 3.
Table 3. p-values for correlation between subtest results and developmental age
subtest Pearson’s correlation coefficient p-value
MOT mean latency -0,171 P= 0,268
prm numbers correct 0,336 P=0,070
PRM scoring difference between 
direct and delayed recall
-0,17 P=0,932
ied stages completed -0,052 P=0,829
pal stages completed 0,256 P=0,306
Table 4. Crosstabulations of simplified CANTAB tasks
The crosstabulations show for all tests a significant (**) higher drop-out than expected by chance. 
MOT Ks Contrast group
Completed 17 30
Expected 20,1 26,9
Pearson X2, Monte Carlo 2-zijdig= 0,048**
PRM 1st trial Ks Contrast group
Completed 8 24
Expected 13,7 18,3
Pearson X2, Monte Carlo 2-zijdig= 0,004**
PRM delayed Ks Contrast group
Completed 6 24
Expected 12,9 17,1
Pearson X2, Monte Carlo 2-zijdig=0,001**
IED Ks Contrast group
Completed 1 19
Expected 8,6 11,4
Pearson X2, Monte Carlo 2-zijdig= 0,00**
PAL Ks Contrast group
Completed 1 17
Expected 7,7 10,3
Pearson X2, Monte Carlo 2-zijdig= 0,001**
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neurocognitive testing with the simplified subtests of the 
CANTAB can be successfully applied in subjects with a 
moderate to severe id and some tests even in profound 
ID. Previously, some computerized neurocognitive tests 
were successfully applied in Down Syndrome (Edgin et 
al. 2010, Liogier d’Ardhuy et al. 2015) and Williams 
Syndrome (Rhodes et al. 2010), but in both groups, the 
level of ID is less pronounced with a main focus on 
borderline, mild and moderate ID. However, to the best 
of our knowledge, the current simplified versions of the 
four Cantab subtests have never been tested before 
in the ID population. This may provide opportunities 
to collect data in different countries, since the tests are 
independent of language. 
Secondly, on inter-individual level, our results 
indicate that there is no significant relation between 
subtest-performance and the level of functioning. in 
continuation of this, it turned out that the Ks group 
had a lower performance rate and a longer median 
latency. This was consistent with our observations that 
subjects with KS needed much more time for action 
and reaction and were easily over stimulated. Because 
of high levels of unfocused attention, it was often not 
possible to complete IED and PAL for which sustained 
attention is needed. Their latency results on the MOT 
subtest, expressed in milliseconds, was even longer 
Intra-individual factors
Finally, we looked at Intra individual results. In 
Box 1, by means of three case examples, the relation 
between individual test results and treatment advice is 
described in detail.  In a number of patients with KS, 
the slow latency time was not taken into account in 
daily living tasks (for example at school). Adjustments 
like giving a person more time to perform a task and 
stimulating activities, lead to a more optimal daily 
guidance. Other examples include the optimal benefit 
taking of the attention span (which could be measured 
exactly during test performance) for school tasks and 
the lowering the level of anxiety by providing more 
external structure and overview. 
discussion
In this study, we set out to determine the applicability 
of computerized neurocognitive testing in patients 
with moderate to profound ID, using simplified test 
of the CANTAB. Also, we wanted to study whether 
neurocognitive data may have specific characteristics in 
different genetic syndromes. Firstly, our results indicate, 
on overall level of performance, that computerized 
Box 1. Case descriptions
Subject X is a 30 years old female, who completed all 4 simplified CANTAB tasks. 
Results:  She showed remarkable accuracy in her performance and reduced latency times for all tests, 
compared to her results. Direct recall was present for simple stimuli. However, direct recall of more complex 
stimuli and visual memory were impaired. Switching between paradigms was too complex for her. She was 
able to complete all tests, but with continuation of test administration, she showed problems with sustained 
attention and her latency time reduced even more.  
Advice:  The high level of accuracy in combination with her reduced latencies point out the importance of 
having enough time to complete tasks. In other words, based on her output, her environment will easily ask too 
much from her,  leading to overstimulation. We advice to give her extra time to complete daily living tasks, like 
getting dressed in the morning. 
Based on the problems with switching, her cognitive flexibility will be low. She needs help for this by making 
daily life more predictable. For example with a visualized (part-time) day programm. Tasks that are offered, 
should ask a maximum of 15 minutes effort from her, due to her limited attention span. Ideally, these are 
interspersed with moments of rest. 
Subject Y is a 5,5 years old girl, diagnosed with a microdeletion at chromosome 17q21.31 resulting in 
KoolendeVries syndrome. She was able to complete all 4 subtests and was keen in managing the tablet.  
Results:  This girl scored at the norm for biological age for speed of processing and accuracy at simple tasks. 
In the more complex tasks (after some patterns of the PRM and the complete IED and PAL) she showed a 
worse performance at learning ability, cognitive flexibility and memory. She took advantage of repeated 
practice. 
Advice:  It was adviced to help this girl with external structure and overview as well as repetition of daily 
tasks. External help was also adviced to practice skills in new situations. Her level of anxiety declined after 
the help was more focused on training and providing help rather than on taking things over. Her self esteem 
increased. 
Subject Z is a 8 year old boy, diagnosed with a ANKRD11 mutation (KBG Syndrome). He was able to 
complete all 4 tasks with some positive feedback (“wow, you already finished 3 tests, just one left!)”. 
Results:   He had normscores, adequate for biological age, on the visual memory tasks, but during the test 
performance, his attention span declined. For this reason the results on the last memory task (visuospatial 
memory) was poor. His speed of processing was high, but this was at the expense of his accuracy. The 
performance on task switching was at the lower end of the norm for his biological age.  
Advice: It was adviced to provide short, concrete/actual instruction before starting a new task and substantiate 
this with a visual clue. Independent taskperformance at school was adapted to his attention span and after 
5-10 minutes another visual clue together with positive feedback was given (“well done!”) to help him sustain 
attention. External help and extra tasks on accuracy were provided to practice and these were planned at the 
start of a school day, when his attention was best.  
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test performance. This is important because not only 
performance results, but also behavioral aspects during 
performance give clues about strengths and weaknesses 
of the subject.
in sum, the use of computerized neurocognitive 
assessment provides the opportunity to collect objective 
measures in a population where it is often difficult 
to get direct information of the subjects themselves. 
We suggest that a first step could be to enhance of 
the accessibility of the CANTAB-tests for the ID 
population. An advantage of the simplified versions 
is that verbal instruction is hardly necessary. The 
principle of Computerized Adaptive Testing (CAT), in 
which test administration can be specifically adjusted 
to the abilities of the subjects, should be applied in this 
population. the Cat method has its theoretical roots 
in multidimensional assessment of personality, and 
allows to leave fixed algorithms for test-items, adjust 
the items more specific to the test-subject (Segall 1996). 
According tot Wang et al. 2012, the application of CAT 
in the neurocognitive domain holds the promise of more 
accurate measurement of intra-individual diagnostic 
factors. It therefore may be an important tool for 
tailored treatment and treatment monitoring. the latter 
may hold in particular for the objective observation 
of the natural course of genetic disorder, not only to 
establish cognitive decline, but also to monitor and 
clarify putative treatment effects in the ID population. 
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those of EHMT animal models (Benevento et al. 2017). 
Nor could we relate our results to previous research in 
Down Syndrome (Edgin et al. 2010, Liogier d’Ardhuy 
et al. 2015) or Williams syndrome (Rhodes et al. 2010). 
The patients with a younger biological age showed 
plenty of practice operating the touchscreen compared 
to the older ones. this might be due to the spirit of the 
times, in which the younger ones grew up with regular 
exposure to touchscreens, e.g. of smartphones and 
tablets. 
Finally, on intra-individual level, it was possible 
to point out strengths and weaknesses of the subject, 
based on test results and systematic observation 
associated with test administration. Based on these, 
specific targets can be formulated for individualized 
treatment and daily guidance. In our cohort, in 
several cases, this turned out to be useful in providing 
directions for stimulating the development and 
breaking through problem behaviors and/ or psychiatric 
symptoms. Although the advices were not new (slowing 
down speed of processing, providing external structure 
and overview), the CANTAB was helpful in the precise 
tailoring of the advices to the subject’s needs and in 
particular, in matching the timing of help to the needs. 
This appeared to be specifically useful for (specialized) 
schools and day care centers but also for guidance at 
home. 
A possible weakness of this study is the relatively 
small number of participants. This study nonetheless 
shows that with proper assessment tools, a more 
personalized treatment and guidance of people with 
moderate to severe ID is to some extent feasible. 
Previous work in Noonan Syndrome has also shown 
this to be the case (Roelofs et al. 2015, Roelofs et al. 
2016). Those who work with people with moderate to 
severe ID should be aware of this and make efforts to 
provide adequate neurocognitive assessment for their 
patients. the focus is often on controlling disruptive 
behavior, rather than focusing on neurocognitive 
characteristic’s that could provide insight in capacities 
and limitations of a patient. furthermore it provides 
opportunities to collect and combine data on genetic 
syndromes in different countries, since these tests 
are independent of language. this is an important 
aspect for future research and the field should built 
international networks for exchanging data of relatively 
rare genetic neuropsychiatric disorders and make an 
effort to develop standardized tests to achieve good 
standard scores. Ideally, for adequate neurocognitive 
testing, an observation schedule should be developed, 
to standardize observations during computerized 
In summary, we recommend the use of the simplified 
CANTAB versions in neurocognitive assessments 
in the ID population. The results of these tests 
are helpful in diagnostic procedures, formulating 
personalized treatment and guidance as well as 
to enhance specific knowledge about genetic 
syndromes. 
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